miR-223 is overexpressed in cancer cells and participates in the development of resistance to multiple anticancer drugs by down-regulating FBXW7 expression (Wang et al., 2020; Ding et al., 2018; Zhou et al., 2015b; Eto et al., 2015; Zhang et al., 2017). Here, FBXW7 is linked to cancer.